Zowinda Technology Co., LTD, a global leader in pharmaceutical packaging solutions, today unveiled its MC-75 Intelligent Cartoning System, setting new standards for regulatory adaptability in medical patch packaging. The launch responds to the 32% surge in global transdermal patch demand (Grand View Research, 2024).
The MC-75 introduces region-specific compliance packages, enabling manufacturers to:
✔ Switch between FDA/EMA/PMDA protocols in <15 minutes
✔ Auto-generate UDI, DSCSA, and MDR documentation
✔ Validate packaging lines 40% faster than conventional systems
"With 78% of packaging delays caused by regulatory changes*, our plug-and-play compliance modules are game-changers," said Dr. Emily Zhao, Zowinda's Regulatory Affairs Director.
Source: 2024 Pharmaceutical Packaging Trends Report
1. Smart Compliance Engine
Real-time regulation updates via cloud connectivity
Self-adjusting parameters for:
→ Child-resistant packaging (US/Canada)
→ Sustainable material modes (EU Green Deal)
→ Traditional medicine pictograms (Asia)
2. Ultra-Flexible Production
Processes 18 SKUs per shift without tool changes
Handles novel formats:
→ CBD patches (0.3mm thin)
→ Herbal compresses (up to 150×200mm)
3. Sustainability Leadership
37% less glue waste vs. industry average
Compatible with 100% PCR materials
Case Study: Top 3 Pharma Company
Challenge: Simultaneous FDA/EMA submissions for new pain patch
Solution: MC-75 with dual-compliance package
Results:
▸ 6-week faster approval vs traditional systems
▸ Zero packaging-related deficiencies in audits
Market | Ready-to-Ship Configuration | Local Support |
---|---|---|
USA | FDA 510(k) Pre-Validated | 24/7 audit hotline |
EU | MDR Article 17 Certified | Notified Body partners |
Japan | PMDA J-GMP Optimized | Onsite validation teams |
Limited-Time Offer:
Free regulatory gap analysis ($25,000 value)
Priority access to cannabis/CBD packaging kit
We are ready to answer your questions.